Eagle Rock Investment Company LLC Has $7.86 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Eagle Rock Investment Company LLC reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 22.2% in the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 16,832 shares of the company’s stock after selling 4,800 shares during the quarter. HCA Healthcare makes up about 1.1% of Eagle Rock Investment Company LLC’s portfolio, making the stock its 24th largest holding. Eagle Rock Investment Company LLC’s holdings in HCA Healthcare were worth $7,858,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Cerity Partners LLC lifted its stake in shares of HCA Healthcare by 13.1% in the third quarter. Cerity Partners LLC now owns 43,920 shares of the company’s stock worth $18,719,000 after acquiring an additional 5,092 shares during the period. National Pension Service lifted its position in shares of HCA Healthcare by 2.9% in the 3rd quarter. National Pension Service now owns 626,585 shares of the company’s stock worth $267,051,000 after purchasing an additional 17,531 shares during the period. Savant Capital LLC increased its position in shares of HCA Healthcare by 37.7% during the third quarter. Savant Capital LLC now owns 4,548 shares of the company’s stock worth $1,938,000 after buying an additional 1,246 shares during the period. Sector Gamma AS lifted its holdings in HCA Healthcare by 36.0% in the third quarter. Sector Gamma AS now owns 10,883 shares of the company’s stock valued at $4,638,000 after buying an additional 2,883 shares during the period. Finally, AlphaQuest LLC grew its holdings in HCA Healthcare by 2,855.2% during the 3rd quarter. AlphaQuest LLC now owns 5,999 shares of the company’s stock worth $2,557,000 after acquiring an additional 5,796 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities research analysts recently commented on HCA shares. Jefferies Financial Group upped their target price on HCA Healthcare from $535.00 to $590.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. JPMorgan Chase & Co. boosted their price target on HCA Healthcare from $420.00 to $535.00 and gave the company a “neutral” rating in a research note on Friday, February 20th. Wall Street Zen lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Wells Fargo & Company increased their target price on shares of HCA Healthcare from $452.00 to $481.00 and gave the stock an “equal weight” rating in a research note on Friday, January 30th. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Sixteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $537.73.

HCA Healthcare Trading Down 1.6%

Shares of HCA stock opened at $472.47 on Friday. HCA Healthcare, Inc. has a 12 month low of $314.43 and a 12 month high of $556.52. The firm has a market capitalization of $105.63 billion, a PE ratio of 16.65, a price-to-earnings-growth ratio of 1.47 and a beta of 1.34. The firm has a fifty day simple moving average of $510.69 and a two-hundred day simple moving average of $475.54.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same period last year, the company earned $6.22 earnings per share. The business’s revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be issued a $0.78 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio is 10.99%.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the sale, the executive vice president owned 8,853 shares in the company, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total value of $2,020,000.00. Following the sale, the senior vice president owned 44,379 shares in the company, valued at $22,411,395. This trade represents a 8.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 15,214 shares of company stock worth $7,797,595. 1.50% of the stock is owned by corporate insiders.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.